CY1116784T1 - Αντιμικροβιακες ενωσεις και μεθοδοι για χρηση αυτων - Google Patents

Αντιμικροβιακες ενωσεις και μεθοδοι για χρηση αυτων

Info

Publication number
CY1116784T1
CY1116784T1 CY20151100909T CY151100909T CY1116784T1 CY 1116784 T1 CY1116784 T1 CY 1116784T1 CY 20151100909 T CY20151100909 T CY 20151100909T CY 151100909 T CY151100909 T CY 151100909T CY 1116784 T1 CY1116784 T1 CY 1116784T1
Authority
CY
Cyprus
Prior art keywords
methods
antimicrobial compounds
protonated compounds
provides
antimicrobial activity
Prior art date
Application number
CY20151100909T
Other languages
Greek (el)
English (en)
Inventor
Roderic M K Dale
Steven L Gatton
Amy Arrow
Terry Thompson
Original Assignee
Lakewood-Amedex, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lakewood-Amedex, Inc filed Critical Lakewood-Amedex, Inc
Publication of CY1116784T1 publication Critical patent/CY1116784T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing acyclic or cycloaliphatic radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
CY20151100909T 2001-05-03 2015-10-08 Αντιμικροβιακες ενωσεις και μεθοδοι για χρηση αυτων CY1116784T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/847,654 US20020032164A1 (en) 1998-12-30 2001-05-03 Antimicrobial compounds and methods for their use
EP10184218.5A EP2311466B1 (en) 2001-05-03 2002-05-03 Antimicrobial compounds and methods for their use

Publications (1)

Publication Number Publication Date
CY1116784T1 true CY1116784T1 (el) 2017-03-15

Family

ID=25301163

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100909T CY1116784T1 (el) 2001-05-03 2015-10-08 Αντιμικροβιακες ενωσεις και μεθοδοι για χρηση αυτων

Country Status (10)

Country Link
US (2) US20020032164A1 (enExample)
EP (2) EP1389909B1 (enExample)
JP (4) JP4347573B2 (enExample)
AU (1) AU2002305336B2 (enExample)
CA (2) CA2445381C (enExample)
CY (1) CY1116784T1 (enExample)
DK (1) DK2311466T3 (enExample)
ES (1) ES2549766T3 (enExample)
PT (1) PT2311466E (enExample)
WO (1) WO2002089581A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US6627215B1 (en) * 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
EP2351765A3 (en) * 2001-07-10 2012-02-22 Lakewood-Amedex, Inc Oligonucleotide-containing pharmacological compositions and their use
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
EP1680414A4 (en) * 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv SUBSTITUTED INDAZOLE-O-GLUCOSIDE
ES2402098T5 (es) * 2003-08-01 2021-06-09 Mitsubishi Tanabe Pharma Corp Compuestos novedosos que tienen actividad inhibidora frente a transportador dependiente de sodio
TW200727785A (en) * 2005-11-25 2007-08-01 Maruishi Pharma Gel composition for antibacterial sterilization
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
WO2008135085A1 (en) * 2007-05-04 2008-11-13 Symrise Gmbh & Co. Kg Synergistic active preparations comprising 1,2-decanediol and further antimicrobial active compounds
NO2200606T3 (enExample) * 2007-09-10 2018-03-24
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
GB2460445B (en) * 2008-05-30 2012-07-11 Vernolix Ltd Treatment of ringworm
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) * 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CN102482250B (zh) 2009-07-10 2014-11-19 詹森药业有限公司 1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯的结晶方法
WO2011047113A1 (en) * 2009-10-14 2011-04-21 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
JP6227406B2 (ja) 2010-05-11 2017-11-08 ヤンセン ファーマシューティカ エヌ．ベー． ＳＧＬＴの阻害剤としての１−（β−Ｄ−グルコピラノシル）−２−チエニル−メチルベンゼン誘導体を含有する医薬製剤
WO2012140120A1 (en) 2011-04-13 2012-10-18 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
US9035044B2 (en) 2011-05-09 2015-05-19 Janssen Pharmaceutica Nv L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
US11377468B2 (en) 2017-03-10 2022-07-05 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US12030908B2 (en) 2017-03-10 2024-07-09 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
ES2987873T3 (es) 2017-03-10 2024-11-18 Lakewood Amedex Inc Compuestos antimicrobianos, composiciones y usos de los mismos
EP3638251B1 (en) 2017-06-12 2024-03-06 Lakewood Amedex, Inc. Bisphosphocin gel formulations and uses thereof
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
SG11202103180QA (en) 2018-10-17 2021-05-28 Lakewood Amedex Inc Methods and compositions for treating oral mucositis
CZ2019769A3 (cs) * 2019-12-12 2021-09-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i. Lipofosfonoxiny třetí generace, jejich příprava a použití
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
KR20220009630A (ko) * 2020-07-16 2022-01-25 정준영 플라즈마를 이용한 마스크 폐기 처리기
CN115448967A (zh) * 2022-09-26 2022-12-09 泽同医药科技(南通)有限公司 一种吩噁嗪半乳烯糖碳苷化合物及其合成方法
WO2025179296A1 (en) * 2024-02-22 2025-08-28 Lakewood Amedex, Inc. Crystalline forms of nu-3 and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
DE2916318A1 (de) * 1979-04-23 1980-11-06 Hoechst Ag Waesserige desinfektionsloesung
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4908209A (en) * 1983-08-16 1990-03-13 Interface, Inc. Biocidal delivery system of phosphate ester and method of preparation thereof
JPS60209077A (ja) * 1984-03-27 1985-10-21 竹本油脂株式会社 繊維処理用油剤及び該油剤による合成繊維糸の処理方法
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
DE3542516A1 (de) 1985-12-02 1987-06-04 Henkel Kgaa Desinfektionsmittel
AU2426688A (en) * 1987-08-03 1989-03-01 Interface Research Corporation Microbiocidal cleansing of disinfectant formulations and preparation therof
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
ZA902710B (en) 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5420330A (en) * 1990-09-07 1995-05-30 Pharmacia P-L Biochemicals Inc. Lipo-phosphoramidites
EP0622373A1 (en) * 1990-12-07 1994-11-02 The Upjohn Company Phosphonic acid derivatives useful as anti-inflammatory agents
US5811568A (en) * 1992-10-08 1998-09-22 Shaman Pharmaceuticals, Inc. Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
US5681829A (en) * 1992-10-08 1997-10-28 Shaman Pharmaceuticals, Inc. Class of phosphocholine derivatives having antifungal activity
JPH08502298A (ja) * 1992-10-08 1996-03-12 シェイマン ファーマシューティカル，インコーポレーテッド 抗真菌活性をもつ新規クラスのホスホコリン誘導体
DE4333385C2 (de) 1993-09-30 1997-01-30 Friedrich A Spruegel Flächendesinfektions- und Reinigungsmittel
FR2718022B1 (fr) 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2727289B1 (fr) * 1994-11-30 1999-03-05 Derives Resiniques Terpenique Composition desinfectante comprenant au moins un alcool terpenique et au moins un tensio-actif acide bactericide, et utilisation de tels tensio-actifs
CA2238484A1 (en) * 1995-11-28 1997-06-05 Michael D. Wider Antimicrobial composition and methods of use therefor
US5843998A (en) 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US6211349B1 (en) * 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US6610314B2 (en) * 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations

Also Published As

Publication number Publication date
JP5883838B2 (ja) 2016-03-15
US20050107344A1 (en) 2005-05-19
JP5503900B2 (ja) 2014-05-28
EP2311466B1 (en) 2015-07-08
JP4347573B2 (ja) 2009-10-21
JP2014055139A (ja) 2014-03-27
CA2445381C (en) 2013-09-17
JP2016056177A (ja) 2016-04-21
DK2311466T3 (en) 2015-10-19
CA2827671A1 (en) 2002-11-14
CA2445381A1 (en) 2002-11-14
EP1389909A4 (en) 2005-03-30
WO2002089581A1 (en) 2002-11-14
PT2311466E (pt) 2015-10-27
JP2009179639A (ja) 2009-08-13
EP2311466A3 (en) 2012-04-25
EP2311466A2 (en) 2011-04-20
EP1389909B1 (en) 2012-07-18
ES2549766T3 (es) 2015-11-02
US7176191B2 (en) 2007-02-13
US20020032164A1 (en) 2002-03-14
JP2005511482A (ja) 2005-04-28
EP1389909A1 (en) 2004-02-25
CA2827671C (en) 2016-07-05
AU2002305336B2 (en) 2007-11-08
JP6097372B2 (ja) 2017-03-15

Similar Documents

Publication Publication Date Title
CY1116784T1 (el) Αντιμικροβιακες ενωσεις και μεθοδοι για χρηση αυτων
EA200600602A1 (ru) Синергические фунгицидные комбинации биологически активных веществ
BR0307924A (pt) N-aril-2-oxazolidinona-5-carboxamidas e seus derivados
PT1453512E (pt) Derivados de acetileno tendo actividade antagonistica do mglur 5
NO20052787L (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
CY1110821T1 (el) Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
DK1709044T4 (da) Oxazolidinon-quinolon-hybridantibiotika
CY1105137T1 (el) Παραγωγα αμινοκυκλοεξυλ αιθερων και χρησεις τους
DK1531672T3 (da) Antimikrobielle sammensætninger
PT1289366E (pt) Combinacoes fungicidas de substancias activas
ATE397861T1 (de) Synergistische zusammensetzungen
UA83266C2 (en) Oxazole derivatives of tetracyclines
EA200702175A1 (ru) Синергические фунгицидные комбинации биологически активных веществ
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DE60025494D1 (de) Epothilon zusammensetzungen
TW200602295A (en) Organic compounds
TR199901209T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
PL372769A1 (en) Cyanoguanidine prodrugs
PT1268475E (pt) Novos agentes bacterianos de benzosultam-oxazolidinona
ATE321760T1 (de) N-aryl-2-oxazolidinone und deren derivate
BRPI0413744A (pt) n-aril-2-ciano-oxazolidinonas e seus derivados